Suppr超能文献

物质使用、社会人口特征与寻求新南威尔士州酒精和其他药物治疗者的自评健康:一项队列研究的基线结果。

Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study.

机构信息

Drug and Alcohol Services, South Eastern Sydney Local Health District, Sydney, NSW.

Central Clinical School, the University of Sydney, Sydney, NSW.

出版信息

Med J Aust. 2023 Sep 4;219(5):218-226. doi: 10.5694/mja2.52039. Epub 2023 Jul 14.

Abstract

OBJECTIVE

To investigate the demographic characteristics, substance use, and self-rated health of people entering treatment in New South Wales public health services for alcohol, amphetamine-type stimulants, cannabis, cocaine, or opioids use, by principal drug of concern.

DESIGN

Baseline findings of a cohort study; analysis of data in patient electronic medical records and NSW minimum data set for drug and alcohol treatment services.

SETTING, PARTICIPANTS: People completing initial Australian Treatment Outcomes Profile (ATOP) assessments on entry to publicly funded alcohol and other drug treatment services in six NSW local health districts/networks, 1 July 2016 - 30 June 2019.

MAIN OUTCOME MEASURES

Socio-demographic characteristics, and substance use and self-rated health (psychological, physical, quality of life) during preceding 28 days, by principal drug of concern.

RESULTS

Of 14 087 people included in our analysis, the principal drug of concern was alcohol for 6051 people (43%), opioids for 3158 (22%), amphetamine-type stimulants for 2534 (18%), cannabis for 2098 (15%), and cocaine for 246 (2%). Most people commencing treatment were male (9373, 66.5%), aged 20-39 years (7846, 50.4%), and were born in Australia (10 934, 86.7%). Polysubstance use was frequently reported, particularly by people for whom opioids or amphetamine-type stimulants were the principal drugs of concern. Large proportions used tobacco daily (53-82%, by principal drug of concern group) and reported poor psychological health (47-59%), poor physical health (32-44%), or poor quality of life (43-52%).

CONCLUSIONS

The prevalence of social disadvantage and poor health is high among people seeking assistance with alcohol, amphetamine-type stimulants, cannabis, cocaine, or opioids use problems. Given the differences in these characteristics by principal drug of concern, health services should collect comprehensive patient information during assessment to facilitate more holistic, tailored, and person-centred care.

摘要

目的

通过主要关注药物,调查进入新南威尔士州公共卫生服务机构治疗酒精、苯丙胺类兴奋剂、大麻、可卡因或阿片类药物使用的人群的人口统计学特征、物质使用和自我评估健康状况。

设计

队列研究的基线结果;对患者电子病历和新南威尔士州药物和酒精治疗服务最低数据集中的数据分析。

地点、参与者:2016 年 7 月 1 日至 2019 年 6 月 30 日,在新南威尔士州六个地方卫生区/网络的公共资助酒精和其他药物治疗服务中完成初始澳大利亚治疗结果简介(ATOP)评估的人。

主要结果措施

主要关注药物的社会人口统计学特征,以及在过去 28 天内的物质使用和自我评估健康状况(心理、生理、生活质量)。

结果

在我们的分析中,有 14087 人,主要关注的药物是酒精的有 6051 人(43%),阿片类药物的有 3158 人(22%),苯丙胺类兴奋剂的有 2534 人(18%),大麻的有 2098 人(15%),可卡因的有 246 人(2%)。大多数开始治疗的人是男性(9373 人,66.5%),年龄在 20-39 岁(7846 人,50.4%),并在澳大利亚出生(10934 人,86.7%)。经常报告多药物使用,特别是对于阿片类药物或苯丙胺类兴奋剂为主要药物的人。大量人每天使用烟草(按主要药物关注组,53-82%),报告心理健康状况不佳(47-59%),身体健康状况不佳(32-44%)或生活质量差(43-52%)。

结论

在寻求酒精、苯丙胺类兴奋剂、大麻、可卡因或阿片类药物使用问题帮助的人群中,社会劣势和健康状况不佳的比例很高。鉴于主要药物关注点的差异,卫生服务机构应在评估过程中收集全面的患者信息,以促进更全面、更有针对性和以患者为中心的护理。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验